Literature DB >> 30012765

Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.

Qun Yan1,2, Melissa J Karau1, Yash S Raval1, Robin Patel3,4.   

Abstract

The antibiofilm activity of oritavancin in combination with rifampin, gentamicin, or linezolid was evaluated against 10 prosthetic joint infection (PJI)-related methicillin-resistant Staphylococcus aureus (MRSA) isolates by time-kill assays. Oritavancin combined with rifampin demonstrated statistically significant bacterial reductions compared with those of either antimicrobial alone for all 10 isolates (P ≤ 0.001), with synergy being observed for 80% of the isolates. Oritavancin and rifampin combination therapy may be an option for treating MRSA PJI.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  biofilm; gentamicin; linezolid; methicillin-resistant Staphylococcus aureus; oritavancin; rifampin

Mesh：

Substances：

Year:  2018        PMID： 30012765      PMCID： PMC6153823          DOI： 10.1128/AAC.00943-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  Brian J Werth
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

2.  Oritavancin: mechanism of action.

Authors:  George G Zhanel; Frank Schweizer; James A Karlowsky
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

3.  A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus.

Authors:  Katie E Barber; Brian J Werth; John P McRoberts; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing.

Authors:  Qun Yan; Melissa J Karau; Robin Patel
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

5.  In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus.

Authors:  Corinne Ruppen; Andrew Hemphill; Parham Sendi
Journal:  J Antimicrob Chemother       Date:  2016-12-20       Impact factor: 5.790

6.  Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013-2014).

Authors:  Leonard R Duncan; Helio S Sader; Robert K Flamm; Ronald N Jones; Rodrigo E Mendes
Journal:  Diagn Microbiol Infect Dis       Date:  2016-07-27       Impact factor: 2.803

7.  Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.

Authors:  Jose L del Pozo; Mark S Rouse; Jayawant N Mandrekar; Marta Fernandez Sampedro; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

Review 8.  Prosthetic joint infection.

Authors:  Aaron J Tande; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm.

Authors:  Jorge Parra-Ruiz; Alejandra Bravo-Molina; Alejandro Peña-Monje; José Hernández-Quero
Journal:  J Antimicrob Chemother       Date:  2012-07-13       Impact factor: 5.790

Review 10.  Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents.

Authors:  Shriti Singh; Santosh Kumar Singh; Indrajit Chowdhury; Rajesh Singh
Journal:  Open Microbiol J       Date:  2017-04-28
View more
  8 in total

Review 1.  Rifamycin antibiotics and the mechanisms of their failure.

Authors:  Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2021-08-16       Impact factor: 2.649

Review 2.  New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides.

Authors:  Truc T Tran; Sara Gomez Villegas; Samuel L Aitken; Susan M Butler-Wu; Alex Soriano; Brian J Werth; Jose M Munita
Journal:  Antimicrob Agents Chemother       Date:  2022-04-27       Impact factor: 5.938

Review 3.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

4.  Prevalence and Characterization of Staphylococcus aureus Isolated From Women and Children in Guangzhou, China.

Authors:  Bingshao Liang; Jialiang Mai; Yunfeng Liu; Yanmei Huang; Huamin Zhong; Yongqiang Xie; Qiulian Deng; Lianfen Huang; Shuwen Yao; Yanming He; Yan Long; Yiyu Yang; Sitang Gong; Hongling Yang; Zhenwen Zhou
Journal:  Front Microbiol       Date:  2018-11-16       Impact factor: 5.640

5.  In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.

Authors:  Hye-Kyung Cho; Melissa J Karau; Kerryl E Greenwood-Quaintance; Karl A Hansford; Matthew A Cooper; Mark A T Blaskovich; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

6.  Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series.

Authors:  James B Doub; Emily L Heil; Afua Ntem-Mensah; Renaldo Neeley; Patrick R Ching
Journal:  Antibiotics (Basel)       Date:  2020-06-13

7.  Modulated Response of Aspergillus fumigatus and Stenotrophomonas maltophilia to Antimicrobial Agents in Polymicrobial Biofilm.

Authors:  Lolita Roisin; Elise Melloul; Paul-Louis Woerther; Guilhem Royer; Jean-Winoc Decousser; Jacques Guillot; Eric Dannaoui; Françoise Botterel
Journal:  Front Cell Infect Microbiol       Date:  2020-10-06       Impact factor: 5.293

8.  Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice.

Authors:  Milo Gatti; Simona Barnini; Fabio Guarracino; Eva Maria Parisio; Michele Spinicci; Bruno Viaggi; Sara D'Arienzo; Silvia Forni; Angelo Galano; Fabrizio Gemmi
Journal:  Antibiotics (Basel)       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.